215 related articles for article (PubMed ID: 37453389)
1. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
[TBL] [Abstract][Full Text] [Related]
2. Rapid and simultaneous determination of ten anti-tuberculosis drugs in human plasma by UPLC-MS/MS with applications in therapeutic drug monitoring.
Wang X; Zhang H; Han Y; Huo L; Cao Y; Xu X; Ai L
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122246. PubMed ID: 32668377
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection.
Xing Y; Yin L; Le X; Chen J; Zhang L; Li Y; Lu H; Zhang L
Heliyon; 2021 Jul; 7(7):e07532. PubMed ID: 34296020
[TBL] [Abstract][Full Text] [Related]
4. Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations.
Cheng L; Luo M; Guo Y; Fan Y; Wang P; Zhou G; Qin S; Weng B; Li P; Liu Z; Liu S
Front Pharmacol; 2023; 14():1248331. PubMed ID: 37869746
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
6. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Wu L; Ye Z; Liu H; Guo H; Lin J; Zheng L; Chu N; Liu X
J Pharm Biomed Anal; 2020 Feb; 180():113076. PubMed ID: 31896523
[TBL] [Abstract][Full Text] [Related]
7. Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
Um SW; Lee SW; Kwon SY; Yoon HI; Park KU; Song J; Lee CT; Lee JH
Int J Tuberc Lung Dis; 2007 Sep; 11(9):972-8. PubMed ID: 17705974
[TBL] [Abstract][Full Text] [Related]
8. New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MS.
Karaźniewicz-Łada M; Kosicka-Noworzyń K; Rao P; Modi N; Xie YL; Heysell SK; Kagan L
J Pharm Biomed Anal; 2023 Oct; 235():115650. PubMed ID: 37597382
[TBL] [Abstract][Full Text] [Related]
9. Application of the isoniazid assay in dried blood spots using the ultra-performance liquid chromatography-tandem mass spectrometry.
Lee K; Jun SH; Choi MS; Song SH; Park JS; Lee JH; Park KU; Song J
Clin Biochem; 2017 Oct; 50(15):882-885. PubMed ID: 28427917
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
[TBL] [Abstract][Full Text] [Related]
11. A Simple and Sensitive UPLC-UV Method for Simultaneous Determination of Isoniazid, Pyrazinamide, and Rifampicin in Human Plasma and Its Application in Therapeutic Drug Monitoring.
Jiang Z; Huang L; Zhang L; Yu Q; Lin Y; Fei H; Shen H; Huang H
Front Mol Biosci; 2022; 9():873311. PubMed ID: 35573738
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application.
da Silva LC; Grando AP; de Baco LS; Hahn RZ; Ferreira Filho AF; Brucker N; Linden R; Antunes MV
J Pharm Biomed Anal; 2023 Oct; 235():115539. PubMed ID: 37517245
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine.
Abouzid M; Kosicka-Noworzyń K; Karaźniewicz-Łada M; Rao P; Modi N; Xie YL; Heysell SK; Główka A; Kagan L
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257250
[TBL] [Abstract][Full Text] [Related]
14. Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS.
Han M; Jun SH; Lee JH; Park KU; Song J; Song SH
J Antimicrob Chemother; 2013 Sep; 68(9):2066-73. PubMed ID: 23657802
[TBL] [Abstract][Full Text] [Related]
15. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Kivrane A; Grinberga S; Sevostjanovs E; Igumnova V; Pole I; Viksna A; Bandere D; Krams A; Cirule A; Pugovics O; Ranka R
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122986. PubMed ID: 34688197
[TBL] [Abstract][Full Text] [Related]
16. Anthropometric and Genetic Factors Associated With the Exposure of Rifampicin and Isoniazid in Mexican Patients With Tuberculosis.
Huerta-García AP; Medellín-Garibay SE; Salazar-González RA; Ortiz-Álvarez A; Magaña-Aquino M; Rodríguez-Pinal CJ; Portales-Pérez DP; Romano-Moreno S; Milán-Segovia RDC
Ther Drug Monit; 2019 Oct; 41(5):648-656. PubMed ID: 30939588
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study.
Hee KH; Seo JJ; Lee LS
J Pharm Biomed Anal; 2015 Jan; 102():253-60. PubMed ID: 25459921
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS.
Vu DH; Koster RA; Bolhuis MS; Greijdanus B; Altena RV; Nguyen DH; Brouwers JR; Uges DR; Alffenaar JW
Talanta; 2014 Apr; 121():9-17. PubMed ID: 24607103
[TBL] [Abstract][Full Text] [Related]
19. A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs.
Baietto L; Calcagno A; Motta I; Baruffi K; Poretti V; Di Perri G; Bonora S; D'Avolio A
J Antimicrob Chemother; 2015 Sep; 70(9):2572-5. PubMed ID: 26066583
[TBL] [Abstract][Full Text] [Related]
20. Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.
Kumar AK; Chandrasekaran V; Kannan T; Murali AL; Lavanya J; Sudha V; Swaminathan S; Ramachandran G
Eur J Clin Pharmacol; 2017 Jan; 73(1):65-70. PubMed ID: 27651240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
